These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Introductory remarks to the review series on gene therapy. Woo SL Trends Genet; 1994 Apr; 10(4):111-2. PubMed ID: 8029824 [No Abstract] [Full Text] [Related]
13. Developing gene therapies for rare diseases: an interview with Geoff MacKay. MacKay G Regen Med; 2021 Oct; 16(10):905-908. PubMed ID: 34622685 [TBL] [Abstract][Full Text] [Related]
14. Development and more. Birchmeier C Semin Cell Dev Biol; 2010 Oct; 21(8):812-3. PubMed ID: 20888421 [No Abstract] [Full Text] [Related]
15. Molecular medicine: a primer for clinicians--part IX human gene therapy. Lindahl R S D J Med; 1996 Feb; 49(2):55-60. PubMed ID: 9122671 [TBL] [Abstract][Full Text] [Related]
17. Cell therapy for neurological disorders. Pandya SK Neurol India; 2016; 64(5):1101. PubMed ID: 27625286 [No Abstract] [Full Text] [Related]
18. Company profile: Tissue regeneration for diabetes and neurological diseases at Living Cell Technologies. Tan PL Regen Med; 2010 Mar; 5(2):181-7. PubMed ID: 20210578 [No Abstract] [Full Text] [Related]
19. Emerging Neurobiological Concepts and Therapies for Neurological Rare Diseases. Bargiotas P Curr Neuropharmacol; 2023; 21(3):438-439. PubMed ID: 36960641 [No Abstract] [Full Text] [Related]
20. [Rare tumors: the need for special centers]. Massard C Bull Cancer; 2014 Feb; 101(2):115. PubMed ID: 25813683 [No Abstract] [Full Text] [Related] [Next] [New Search]